gallstones and glp 1 Gallbladder Risks with GLP-1 Weight Loss Medications Glucagon-Like Peptide-1 Receptor Agonists and

31 Clinically, GLP-1 RA use in patients with diabetes is associated with significant primary risk reduction of several obesity-associated cancers

Localized redness or irritation may occur at the subcutaneous injection site

The nucleotide-binding and oligomerization domain, leucine-rich repeat, and pyrin domain-containing 3 (NLRP3) inflammasome is a multiprotein complex comprising NLRP3, apoptosis speck-like protein (ASC), and pro-caspase-1

If left untreated, it can get worse

Consult your healthcare provider before making any changes to your treatment

Some people respond extremely well, while others lose only a modest amount or discontinue treatment because of side effects, costs, insurance problems, or personal preferences